Remove 2022 Remove Chronic pain management Remove Digital Health Remove Remote care
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. EV to EBITDA: 12.5x Email lloyd@nelsonadvisors.co.uk